NovoCure Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013
Revenue	509.34	537.84	535.03	494.37	351.32	248.07	177.03	82.89	33.09	15.49	Upgrade
Revenue Growth (YoY)	-5.30%	0.53%	8.23%	40.72%	41.62%	40.13%	113.57%	150.52%	113.60%	49.53%	Upgrade
Cost of Revenue	128.28	114.87	114.88	106.5	88.61	80.05	55.61	46.28	20.61	10.04	Upgrade
Gross Profit	381.06	422.97	420.15	387.87	262.71	168.02	121.42	36.61	12.48	5.45	Upgrade
Selling, General & Admin	390.87	306.41	263.18	225.45	184.62	151.12	122.64	110.46	72.73	45.23	Upgrade
Research & Development	223.06	206.09	201.3	132.01	79	50.57	38.1	41.47	43.75	40.38	Upgrade
Operating Expenses	613.93	512.5	464.49	357.46	263.63	201.69	160.75	151.92	116.47	85.61	Upgrade
Operating Income	-232.87	-89.52	-44.33	30.4	-0.91	-33.67	-39.33	-115.32	-104	-80.16	Upgrade
Interest Expense / Income	-41.13	-7.68	7.74	12.3	7.91	12.27	9.17	6.15	3.15	0.14	Upgrade
Other Expense / Income	-	-	-	-	-	-	-0	-	-	-	Upgrade
Pretax Income	-191.74	-81.85	-52.08	18.1	-8.82	-45.94	-48.5	-121.46	-107.15	-80.3	Upgrade
Income Tax	15.3	10.69	6.28	-1.71	-1.59	17.62	13.17	10.38	4.43	0.38	Upgrade
Net Income	-207.04	-92.53	-58.35	19.81	-7.23	-63.56	-61.66	-131.85	-111.58	-80.68	Upgrade
Shares Outstanding (Basic)	106	105	103	101	97	92	89	86	30	12	Upgrade
Shares Outstanding (Diluted)	106	105	103	109	97	92	89	86	30	12	Upgrade
Shares Change	1.65%	1.19%	-5.00%	11.97%	5.89%	3.71%	3.49%	181.43%	143.41%	8.62%	Upgrade
EPS (Basic)	-1.95	-0.88	-0.56	0.20	-0.07	-0.69	-0.70	-1.54	-3.67	-6.46	Upgrade
EPS (Diluted)	-1.95	-0.88	-0.56	0.18	-0.07	-0.69	-0.70	-1.54	-3.67	-6.46	Upgrade
Free Cash Flow	-100.43	9.43	58.59	84.18	16.14	-8.58	-40.5	-125.26	-110.16	-76.56	Upgrade
Free Cash Flow Per Share	-0.94	0.09	0.57	0.83	0.17	-0.09	-0.46	-1.46	-3.62	-6.13	Upgrade
Gross Margin	74.81%	78.64%	78.53%	78.46%	74.78%	67.73%	68.59%	44.16%	37.71%	35.21%	Upgrade
Operating Margin	-45.72%	-16.64%	-8.29%	6.15%	-0.26%	-13.57%	-22.22%	-139.12%	-314.31%	-517.47%	Upgrade
Profit Margin	-40.65%	-17.20%	-10.91%	4.01%	-2.06%	-25.62%	-34.83%	-159.06%	-337.24%	-520.87%	Upgrade
Free Cash Flow Margin	-19.72%	1.75%	10.95%	17.03%	4.59%	-3.46%	-22.88%	-151.11%	-332.93%	-494.27%	Upgrade
Effective Tax Rate	-	-	-	-9.42%	-	-	-	-	-	-	Upgrade
EBITDA	-221.9	-78.9	-34.08	39.55	7.55	-24.67	-31.65	-109.67	-100.84	-78.19	Upgrade
EBITDA Margin	-43.57%	-14.67%	-6.37%	8.00%	2.15%	-9.94%	-17.88%	-132.31%	-304.78%	-504.80%	Upgrade
Depreciation & Amortization	10.97	10.62	10.25	9.15	8.46	9.01	7.68	5.65	3.15	1.96	Upgrade
EBIT	-232.87	-89.52	-44.33	30.4	-0.91	-33.67	-39.33	-115.32	-104	-80.16	Upgrade
EBIT Margin	-45.72%	-16.64%	-8.29%	6.15%	-0.26%	-13.57%	-22.22%	-139.12%	-314.31%	-517.47%	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).